Lacticaseibacillus rhamnosus R0011 and Improved H Pylori Eradication Rates

• Efficacy and safety of Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 as an adjuvant for Helicobacter pylori eradication: a double-blind, randomized, placebo-controlled study.

  • 2023-09-14
  • RCT · n = 160
  • Frontiers in gastroenterology (Lausanne, Switzerland) 2
  • • Anya Kiattiweerasak
    • Natsuda Aumpan
    • Soonthorn Chonprasertsuk
    • Bubpha Pornthisarn
    • Sith Siramolpiwat
    • Patommatat Bhanthumkomol
    • Pongjarat Nunanan
    • Navapan Issariyakulkarn
    • Varocha Mahachai
    • Yoshio Yamaoka
    • Ratha-Korn Vilaichone

  • PubMed: 41821821
  • DOI: 10.3389/fgstr.2023.1245993

  4 Insights on

  • Improved H Pylori Eradication Rates

  • High evidence

  As per-protocol analysis, eradication rates after the 14-day regimen with probiotic or placebo were 90.9% and 75.0% (p=0.047), respectively.

  Effect

  Beneficial

  Effect size

  Moderate

  Significant

  Yes